Research Output per year
Research Output 1986 2019
2016
Erratum to: Inhibition of BRCT(BRCA1)-phosphoprotein interaction enhances the cytotoxic effect of olaparib in breast cancer cells: a proof of concept study for synthetic lethal therapeutic option (Breast Cancer Res Treat, (2012) 134, 511–517, 10.1007/s10549-012-2079-4)
Pessetto, Z. Y., Yan, Y., Bessho, T. & Natarajan, A., Feb 1 2016, In : Breast Cancer Research and Treatment. 155, 3, 1 p.Research output: Contribution to journal › Comment/debate
Phosphoproteins
Breast Neoplasms
Therapeutics
olaparib
2018
Correction: KSR1 is required for cell cycle reinitiation following DNA damage.(Journal of Biological Chemistry (2018)284 (6705– 6715))
Razidlo, G. L., Johnson, H. J., Stoeger, S. M., Cowan, K. H., Bessho, T. & Lewis, R. E., Jan 1 2018, In : Journal of Biological Chemistry. 293, 49, 1 p.Research output: Contribution to journal › Comment/debate
DNA Damage
Cell Cycle
Cells
DNA